BioNTech increases Covid vaccine production target to 2.5bn doses

Gain a global perspective on the US and go beyond with curated news and analysis from 600
journalists in 50+ countries covering politics, business, innovation, trends and more.

Choose your subscription

Trial

Try full digital access and see why over 1 million readers subscribe to the FT

• For 4 weeks receive unlimited Premium digital access to the FT’s trusted, award-winning business news

Read more

Digital

Be informed with the essential

news and opinion

• MyFT – track the topics most important to you
• FT Weekend – full access to the weekend content
• Mobile & Tablet Apps – download to read on the go
• Gift Article – share up to 10 articles a month with family, friends and colleagues

Read more

Print

FT print edition delivered Monday – Saturday along with ePaper access

• Delivery to your home or office Monday to Saturday
• FT Weekend paper – a stimulating blend of news and lifestyle features
• ePaper access – the digital replica of the printed newspaper

Read more

Team or Enterprise

Premium FT.com access for multiple users, with integrations & admin tools

Group Subscription

Premium Digital access, plus:

• Convenient access for groups of users
• Integration with third party platforms and CRM systems
• Usage based pricing and volume discounts for multiple users
• Subscription management tools and usage reporting
• SAML-based single sign-on (SSO)
• Dedicated account and customer success teams

Read more

Or, if you are already a subscriber

Sign in

Read More

http://businessadministrationclass.com/biontech-increases-covid-vaccine-production-target-to-2-5bn-doses/